Heroin addicts' psychopathological subtypes. correlations with the natural history of illness

Heroin Addiction and Related Clinical Problems

Volumn 14, Issue 1, 2012, Pages 11-21

  Maremmani, Angelo Giovanni Icro ^a,b   Rovai, Luca ^a   Pani, Pier Paolo ^d   Maremmani, Icro ^a,b,c  

^a UNIVERSITY OF PISA   (Italy)

^b AU CNS   (Italy)

^c G DE LISIO INSTITUTE OF BEHAVIOURAL SCIENCES   (Italy)

^d Social Health Services   (Italy)

Author keywords

Dual diagnosis; Heroin addiction; Natural history of heroin addiction; Psychopathological subtypes

Indexed keywords

CENTRAL STIMULANT AGENT; PSYCHEDELIC AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANXIETY; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE COURSE; EMOTION; FACTORIAL ANALYSIS; FEMALE; HEROIN DEPENDENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OBSERVATIONAL STUDY; PANIC; PRIORITY JOURNAL; PSYCHOSIS; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCORING SYSTEM; SLEEP DISORDER; SOMATIZATION; SUICIDE; VIOLENCE; WHITE COLLAR WORKER; WORTHLESSNESS;

EID: 84858384105     PISSN: 15921638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. A.P.A. (2000): DSM-IV-TR. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington, DC.
2. Akiskal H. S., Mallya G. (1987): Criteria for the 'soft' bipolar spectrum: Treatment implications. Psychopharmacol Bull. 23: 68-73.
3. Altenkirch H., Kindermann W. (1986): Inhalant abuse and heroin addiction: a comparative study on 574 opiate addicts with and without a history of sniffng. Addict Behav. 11(2): 93-104.
4. Anthony J. C., Tien A. Y., Petronis K. R. (1989): Epidemiologic evidence of cocaine use and panic attacks. Am J Epidemiol. 129(3): 543-549.
5. Aronson T. A., Craig, T.J. (1986): Cocaine precipitation of panic disorder. Am J Psychiatry. 143(5): 643-645.
6. Astals M., Domingo-Salvany A., Buenaventura C. C., Tato J., Vazquez J. M., Martin-Santos R., Torrens M. (2008): Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Subst Use Misuse. 43(5): 612-632.
7. Bandettini Di Poggio A., Fornai F., Paparelli A., Pacini M., Perugi G., Maremmani I. (2006): Comparison between heroin and heroin-cocaine polyabusers: a psychopathological study. Ann NY Acad Sci. 1074: 438-445.
8. Berger P. A., Watson S. J., Akil H., Elliot G. R., Rubin R. T., Pfefferbaum A. (1980): Betaendorphin and schizophrenia. Arch Gen Psychiatry. 37: 635-640.
9. Best D., Day E., Cantillano V., Gaston R. L., Nambamali A., Sweeting R., Keaney F. (2008): Mapping heroin careers: utilising a standardised history-taking method to assess the speed of escalation of heroin using careers in a treatment-seeking cohort. Drug Alcohol Rev. 27(2): 165-170.
10. Bodkin J. A., Zornberg G. L., Lukas S. E., Cole J. O. (1995): Buprenorphine treatment of refractory depression. J Clin Psychopharmacol 15(1): 49-57.
11. Brousse G., Garay R. P., Benyamina A. (2008): [Management of comorbid bipolar disorder and alcohol dependence]. Presse Med. 37(7-8): 1132-1137.
12. Callaway E. (1996): Buprenorphine for depression: the un-adoptable orphan. Biol Psychiatry. 39(12): 989-990.
13. Cassano G. B., Akiskal H. S., Musetti L., Perugi G., Soriani A., Mignani V. (1989): Psychopathology, temperament and paste course in Primary Mayor Depression. Toward a redifnition of Bipolarity with a new semistructured interview for depression. Psychopathology. II 22: 278-288.
14. Clouet D. H. (1982): A biochemical and neurophysiological comparison of opioids and antipsychotics. Ann NY Acad Sci. 398: 130-139.
15. Cocores J. A., Petel M. D., Gold M. S., Pottash A. C. (1987): Cocaine abuse, attention defcit disorder, and bipolar patients. J Nerv Ment Dis. 175(7): 431-432.
16. D'amanda C., Plumb M. M., Taintor Z. (1977): Heroin addicts with a history of glue sniffng: a deviant group within a deviant group. Int J Addict. 12(2-3): 255-270.
17. Darke S., Ross J. (1997): Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend. 48: 135-141.
18. Deglon J. J., Wark E. (2008): Methadone: A Fast and Powerful Anti-anxiety, Anti-depressant and Anti-psychotic Treatment. Heroin Addict Relat Clin Probl. 10(1): 49-56.
19. Du W. J., Xiang Y. T., Wang Z. M., Chi Y., Zheng Y., Luo X. N., Cai Z. J., Ungvari G. S., Gerevich J. (2008): Socio-demographic and clinical characteristics of 3129 heroin users in the frst methadone maintenance treatment clinic in China. Drug Alcohol Depend. 94(1-3): 158-164.
20. Emrich H. M. (1984): Endorphins in psychiatry. Psychiatr Dev. 2(2): 97-114.
21. Extein I., Pottash A. L. C., Gold M. S. (1982): A possible opioid receptor dysfunction in some depressive disorders. Ann NY Acad Sci. 398: 113-119.
22. Gerner R. H., Catlin D. H., Gorelick D. A., Hui K. K., Li C. H. (1980): Beta-endorphin. Intravenous infusion causes behavioral change in psychiatric inpatients. Arch Gen Psychiatry. 37: 642-647.
23. Gold M. S., Pottash A. L. C., Sweeney D. R., Martin D., Extein I. (1982): Antimanic, antidepressant, and antipanic effects of opiate: clinical, neuro-anatomical, and biochemical evidence. Ann NY Acad Sci. 398: 140-150.
24. Haney M., Miczek K. A. (1989): Morphine effects on maternal aggression, pup care and analgesia in mice. Psychopharmacology. 98/1: 68-74.
25. Kalivas P. W., Volkow N. D. (2005): The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 162: 1403-1413.
26. Khantzian E. J. (1982): Psychological (structural) Vulnerabilities and the Specifc Appeal of Narcotics. Ann NY Acad Sci. 398: 24-32.
27. Koo D. J., Chitwood D. D., Sanchez J. (2007): Factors for employment: a case-control study of fully employed and unemployed heroin users. Subst Use Misuse. 42(7): 1035-1054.
28. Krausz M., Degkwitz P., Haasen C., Verthein U. (1996): Opioid addiction and suicidality. Crisis. 17(4): 175-181.
29. Lahmeyer H. W., Channon R. A., Schlemmer F. J. (1988): Psychoactive Substance Abuse. In: Flaherty J. A., Channon R. A., Devis J. M. (Eds.): Psychiatry Diagnosis & Tgerapy. Appleton & Lange, San Mateo, CA. pp. 182-199.
30. Levinson I., Galynker, Ii, Rosenthal R. N. (1995): Methadone withdrawal psychosis. J Clin Psychiatry. 56(2): 73-76.
31. Lynskey M. T., Hall W. (1998): Cohort trends in age of initiation to heroin use. Drug Alcohol Rev. 17(3): 289-297.
32. Maremmani I., Canoniero S., Pacini M. (2000): Methadone dose and retention in treatment of heroin addicts with Bipolar I Disorder comorbidity. Preliminary Results. Heroin Addict Relat Clin Probl. 2(1): 39-46.
33. Maremmani I., Canoniero S., Pacini M. (2002): Psycho(patho)logy of "addiction." Interpretative hypothesis. Ann Ist Super Sanita. 38(3): 241-257.
34. Maremmani I., Canoniero S., Pacini M., Lazzeri A., Placidi G. F. (2000): Opioids and cannabinoids abuse among bipolar patients. Heroin Addict Relat Clin Probl. 2(2): 35-42.
35. Maremmani I., Capone M. R., Aglietti M., Castrogiovanni P. (1994): Heroin dependence and Bipolar Disorders. New Trends in Experimental and Clinical Psychiatry. X: 179-182.
36. Maremmani I., Castrogiovanni P. (1989): DAH-Q: Drug Addiction History Questionnaire. University Press, Pisa.
37. Maremmani I., Marini G., Fornai F. (1998): Naltrexone-induced panic attacks. Am J Psychiatry. 155(3): 447.
38. Maremmani I., Pacini M., Lubrano S., Lovrecic M., Perugi G. (2003): Dual diagnosis heroin addicts. The clinical and therapeutic aspects. Heroin Addict Relat Clin Probl. 5(2): 7-98.
39. Maremmani I., Pacini M., Lubrano S., Perugi G., Tagliamonte A., Pani P. P., Gerra G., Shinderman M. (2008): Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis). Eur Addict Res. 14(3): 134-142.
40. Maremmani I., Pacini M., Pani P. P. (2006): Effectiveness of buprenorphine in double diagnosed patients. Buprenorphine as psychothropic drug. Heroin Addict Relat Clin Probl. 8(1): 31-48.
41. Maremmani I., Pacini M., Pani P. P., Perugi G., Deltito J., Akiskal H. (2007): The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'? Ann Gen Psychiatry. 6: 31.
42. Maremmani I., Pacini M., Perugi G. (2005): Addictive disorders, bipolar spectrum and the impulsive link: The psychopathology of a self-regenerating pathway. Heroin Addict Relat Clin Probl. 7(3): 33-46.
43. Maremmani I., Pacini M., Perugi G., Deltito J., Akiskal H. (2008): Cocaine abuse and the bipolar spectrum in 1090 heroin addicts: clinical observations and a proposed pathophysiologic model. J Affect Disord. 106(1-2): 55-61.
44. Maremmani I., Pacini M., Popovic D., Romano A., Maremmani A. G., Perugi G., Deltito J., Akiskal K., Akiskal H. (2009): Affective temperaments in heroin addiction. J Affect Disord. 117(3): 186-192.
45. Maremmani I., Pacini M., Romano A., Popovic D., Maremmani A. G. I., Deltito J., Perugi G. (2008): Disturbo di Panico ed uso di sostanze: Signifcato clinico e dinamiche psicopatologiche. Giornale Italiano di Psicopatologia/Italian Journal of Psychopathology. 14: 307-315.
46. Maremmani I., Pani P. P., Canoniero S., Pacini M., Perugi G., Rihmer Z., Akiskal H. S. (2007): Is the bipolar spectrum the psychopathological substrate of suicidality in heroin addicts? Psychopathology. 40(5): 269-277.
47. Maremmani I., Pani P. P., Pacini M., Bizzarri J. V., Trogu E., Maremmani A. G. I., Perugi G., Gerra G., Dell'Osso L. (2010): Subtyping Patients with Heroin Addiction at Treatment Entry: Factors Derived fron the SCL-90. Ann Gen Psychiatry. 9(1): 15.
48. Maremmani I., Pani P. P., Pacini M., Perugi G. (2007): Substance use and quality of life over 12 months among buprenorphine maintenance-treated and methadone maintenance-treated heroin-addicted patients. J Subst Abuse Treat. 33(1): 91-98.
49. Maremmani I., Perugi G., Pacini M., Akiskal H. S. (2006): Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm. J Affect Disord. 93(1-3): 1-12.
50. Maremmani I., Popovic D. (2009): Heroin Dependence. In: Maremmani I. (Ed.) The Principles and Practice of Methadone Treatment. Pacini Editore Medicina, Pisa. pp. 21-30.
51. Maremmani I., Zolesi O., Aglietti M., Marini G., Tagliamonte A., Shinderman M., Maxwell S. (2000): Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity. J Addict Dis. 19(2): 29-41.
52. O'Brien M. S., Wu L. T., Anthony J. C. (2005): Cocaine use and the occurrence of panic attacks in the community: a case-crossover approach. Subst Use Misuse. 40(3): 285-297.
53. Pacini M., Maremmani I. (2005): Methadone reduces the need for antipsychotic and antimanic agents in heroin addicts hospitalized for manic and/or acute psychotic episodes. Heroin Addict Relat Clin Probl. 7(4): 43-48.
54. Pacini M., Maremmani I., Vitali M., Santini P., Romeo M., Ceccanti M. (2009): Affective temperaments in alcoholic patients. Alcohol. 43(5): 397-404.
55. Pani P. P., Agus A., Gessa G. L. (1999): Methadone as a mood stabilizer [Letter]. Heroin Addict Relat Clin Probl. 1(1): 43-44.
56. Pani P. P., Maremmani I., Trogu E., Gessa G. L., Ruiz P., Akiskal H. S. (2010): Delineating the psychic structure of substance abuse and addictions: Should anxiety, mood and impulse-control dysregulation be included? J Affect Disord. 122: 185-197.
57. Perez de Los Cobos J., Trujols J., Ribalta E., Pinet C. (2009): A typology of heroin-dependent patients based on their history of self-injurious behaviours. Psychiatry Res. 167(1-2): 169-177.
58. Perugi G., Akiskal H. S., Micheli C., Musetti L., Paiano A., Quilici C., Rossi L., Cassano G. B. (1997): Clinical subtypes of Bipolar Mixed States: Validating a broader European defnition in 143 cases. J Affect Disord. 43: 169-180.
59. Perugi G., Musetti L., Simonini E., Piagentini F., Cassano G. B., Akiskal H. S. (1990): Gender mediated clinical features of depressive illness. The importance of temperamental differences. Br J Psychiatry. 157: 835-841.
60. Roberts C., Horton A. M., Jr. (2001): Sex, ethnicity, age and education effects on the Trail Making Test in a sample of heroin abusers. Int J Neurosci. 110(1-2): 99-106.
61. Rosen M. I., Kosten, T. (1992): Cocaine associated panic attacks in methadone maintained patients. Am J Drug Alcohol Abuse. 18(1): 57-62.
62. Schneider K. (1958): Psychopathic Personalities. Charles C. Thomas, Springfeld, IL.
63. Shaikh M. B., Dalsass M., Siegel A. (1990): Opioidergic Mechanisms Mediating Aggressive Behavior in the Cat. Aggress Behav. 16: 191-206.
64. Spensley J. (1976): Doxepin: A useful adjunct in the treatment of heroin addicts in a methadone program. Int J Addict. 11: 191-197.
65. Tait R. J., Hulse G. K. (2008): Hospital morbidity associated with the natural history of heroin use. J Opioid Manag. 4(5): 321-327.
66. Varga E., Sugerman A. A., Apter J. (1982): The effect of codeine on involutional and senile depression. Ann NY Acad Sci. 398: 103-105.
67. Volovka S. J., Anderson B., Koz G. (1982): Naloxone and naltrexone in mental illness and tardive dyskinesia. Ann N Y Acad Sci. 398: 143-152.